Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 87905-98-4 | MDL No. : | MFCD01863135 |
Formula : | C13H19NO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | TYIYHFWLYLHCHY-UHFFFAOYSA-N |
M.W : | 237.29 | Pubchem ID : | 4072414 |
Synonyms : |
|
Num. heavy atoms : | 17 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.46 |
Num. rotatable bonds : | 9 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 65.89 |
TPSA : | 58.56 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.45 cm/s |
Log Po/w (iLOGP) : | 2.23 |
Log Po/w (XLOGP3) : | 1.83 |
Log Po/w (WLOGP) : | 1.92 |
Log Po/w (MLOGP) : | 1.8 |
Log Po/w (SILICOS-IT) : | 2.16 |
Consensus Log Po/w : | 1.99 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.13 |
Solubility : | 1.75 mg/ml ; 0.00739 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.68 |
Solubility : | 0.496 mg/ml ; 0.00209 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.0 |
Solubility : | 0.0238 mg/ml ; 0.0001 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 2.14 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
71% | With sodium hydrogencarbonate In tetrahydrofuran; water at 0 - 20℃; | To a stirred mixture of 5-amino-1 -pentanol (48.5 mmol, 5.0 g) and sodium bicarbonate (145.4 mmol, 12.2 g) in water (26 mL) at 05C, a solution of benzyl chloroformate (63.1 mmol, 9.0 mL) in anh THF (26 mL) was added dropwise. After stirring at room temperature overnight, reaction mixture was diluted with EtOAc and H20. The organic layer was separated, washed with brine (2x30 mL), dried over anh MgS04, filtered and solvent removed under reduced pressure. The crude was dispersed in the minimum amount of cyclohexane and the resulting solid was filtered and dried under vacuum. The title compound was obtained as a white solid (8.2 g, 71 percent). 1 H NMR (400 MHz, CDCI3) δ 7.35 (m, 5H), 5.09 (2H, s), 4.8 (1 H, brs), 3.65 (2H, m), 3.20 (2H, m), 1 .50-1 .58 (6H, m), 1 .39 (2H, m). |
70% | With sodium hydroxide In water at 20℃; for 22 h; | To a stirred solution of 5-aminopentanol S1 (6.00 g, 0.058 mol, 1.0 eq.) in 1 M aq. NaOH (65 mL) was added CbzCl (9.1 mL, 0.064 mol, 1.1 eq.) in a dropwise fashion. The reaction mixture was stirred at room temperature for 22 h during which time a white precipitate formed. The reaction mixture was filtered in vacuo and washed with water (20 mL) to afford the crude product which was purified by recrystallisation (EtOAc/c-Hex) affording S2 (9.67 g, 70 percent) as a white solid. Rf = 0.2 (c-Hex/EtOAc; 1:1); IR (NaCl, dep. from CH2Cl2) 3320, 2935, 1692, 1543, 1455, 1375, 1272, 1053, 1028 cm-1; HRMS (ESI): calcd. for [C13H19NO3 + Na]+ 260.1263, found 260.1258; 1H NMR (CDCl3, 400 MHz): d 1.33 – 1.47 (m, 2H), 1.48 – 1.65 (m, 4H), 3.21 (app. q, J = 6.4 Hz, 2H), 3.64 (t, J = 6.4 Hz, 2H), 4.78 (br s, 1H), 5.09 (s, 2H), 7.28 – 7.40 (m, 5H) ppm; 13C NMR (CDCl3, 100 MHz): d 22.9 (CH2), 29.8 (CH2), 32.2 (CH2), 40.9 (CH2), 62.7 (CH2), 66.6 (CH2), 128.1 (CH), 128.1 (CH), 128.5 (CH), 136.6 (C), 156.4 (C) ppm. Data are consistent with those reported in literature. |
[ 149423-70-1 ]
Benzyl (cis-4-aminocyclohexyl)carbamate
Similarity: 0.94
[ 27489-63-0 ]
Benzyl (trans-4-hydroxycyclohexyl)carbamate
Similarity: 0.93
[ 46460-73-5 ]
Benzyl (3-aminopropyl)carbamate
Similarity: 0.92
[ 955406-36-7 ]
Benzyl (3-hydroxycyclohexyl)carbamate
Similarity: 0.91
[ 27489-63-0 ]
Benzyl (trans-4-hydroxycyclohexyl)carbamate
Similarity: 0.93
[ 478646-28-5 ]
(R)-Benzyl (1,5-dihydroxypentan-2-yl)carbamate
Similarity: 0.91
[ 955406-36-7 ]
Benzyl (3-hydroxycyclohexyl)carbamate
Similarity: 0.91
[ 939426-84-3 ]
Benzyl (3-hydroxycyclopentyl)carbamate
Similarity: 0.89
[ 648418-25-1 ]
Benzyl 4-hydroxyazepane-1-carboxylate
Similarity: 0.86
[ 149423-70-1 ]
Benzyl (cis-4-aminocyclohexyl)carbamate
Similarity: 0.94
[ 27489-63-0 ]
Benzyl (trans-4-hydroxycyclohexyl)carbamate
Similarity: 0.93
[ 46460-73-5 ]
Benzyl (3-aminopropyl)carbamate
Similarity: 0.92
[ 955406-36-7 ]
Benzyl (3-hydroxycyclohexyl)carbamate
Similarity: 0.91
[ 149423-70-1 ]
Benzyl (cis-4-aminocyclohexyl)carbamate
Similarity: 0.94
[ 27489-63-0 ]
Benzyl (trans-4-hydroxycyclohexyl)carbamate
Similarity: 0.93
[ 46460-73-5 ]
Benzyl (3-aminopropyl)carbamate
Similarity: 0.92
[ 955406-36-7 ]
Benzyl (3-hydroxycyclohexyl)carbamate
Similarity: 0.91